A nem szteroid gyulladásgátló készítmények cardiovascularis mellékhatásai a legújabb ajánlások fényében. Nem veszélyesebb a diclofenac

Translated title of the contribution: Cardiovascular side effects of non-steroidal anti-infl ammatory drugs in the light of recent recommendations

Viktor József Horváth, A. Tabák, Gergely Szabó, Zsuzsanna Putz, Csaba Géza Koós, P. Lakatos

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Among their beneficial effects, non-steroidal anti-inflammatory drugs may also exert several side effects which depend on the dosage and the type of these medications. The most frequent gastrointestinal side effects usually develop shortly after the beginning of their administration, but others such as cardiovascular interactions (which are present much less frequently than gastrointestinal side effects) can also occur after the beginning of drug administration without a latency period. For a long-term treatment, non-steroidal anti-inflammatory drugs are most frequently used in the elderly population where patients typically have high cardiovascular risk and take other medicines, e.g. low dose acetylsalicylic acid that can interact with non-steroidal anti-inflammatory drugs; in this aspect diclofenac may cause less side effects. In this review, the authors briefly review cardiovascular side effects of non-steroidal anti-inflammatory drugs, the processes which potentially influence them, therapeutic consequences and their interaction with acetylsalicylic acid.

Original languageHungarian
Pages (from-to)516-520
Number of pages5
JournalOrvosi Hetilap
Volume156
Issue number13
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Anti-Inflammatory Agents
Pharmaceutical Preparations
Aspirin
Diclofenac
Therapeutics
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A nem szteroid gyulladásgátló készítmények cardiovascularis mellékhatásai a legújabb ajánlások fényében. Nem veszélyesebb a diclofenac. / Horváth, Viktor József; Tabák, A.; Szabó, Gergely; Putz, Zsuzsanna; Koós, Csaba Géza; Lakatos, P.

In: Orvosi Hetilap, Vol. 156, No. 13, 01.03.2015, p. 516-520.

Research output: Contribution to journalArticle

Horváth, Viktor József ; Tabák, A. ; Szabó, Gergely ; Putz, Zsuzsanna ; Koós, Csaba Géza ; Lakatos, P. / A nem szteroid gyulladásgátló készítmények cardiovascularis mellékhatásai a legújabb ajánlások fényében. Nem veszélyesebb a diclofenac. In: Orvosi Hetilap. 2015 ; Vol. 156, No. 13. pp. 516-520.
@article{4d60934bf55342ebaed2e1c3f78a543d,
title = "A nem szteroid gyullad{\'a}sg{\'a}tl{\'o} k{\'e}sz{\'i}tm{\'e}nyek cardiovascularis mell{\'e}khat{\'a}sai a leg{\'u}jabb aj{\'a}nl{\'a}sok f{\'e}ny{\'e}ben. Nem vesz{\'e}lyesebb a diclofenac",
abstract = "Among their beneficial effects, non-steroidal anti-inflammatory drugs may also exert several side effects which depend on the dosage and the type of these medications. The most frequent gastrointestinal side effects usually develop shortly after the beginning of their administration, but others such as cardiovascular interactions (which are present much less frequently than gastrointestinal side effects) can also occur after the beginning of drug administration without a latency period. For a long-term treatment, non-steroidal anti-inflammatory drugs are most frequently used in the elderly population where patients typically have high cardiovascular risk and take other medicines, e.g. low dose acetylsalicylic acid that can interact with non-steroidal anti-inflammatory drugs; in this aspect diclofenac may cause less side effects. In this review, the authors briefly review cardiovascular side effects of non-steroidal anti-inflammatory drugs, the processes which potentially influence them, therapeutic consequences and their interaction with acetylsalicylic acid.",
keywords = "acetilszalicilsav, acetylsalicylic acid, cardiovascular side effects, cardiovascularis mell{\'e}khat{\'a}s, diclofenac, diclofenac, nem szteroid gyullad{\'a}sg{\'a}tl{\'o}, non-steroidal anti-inflammatory agents",
author = "Horv{\'a}th, {Viktor J{\'o}zsef} and A. Tab{\'a}k and Gergely Szab{\'o} and Zsuzsanna Putz and Ko{\'o}s, {Csaba G{\'e}za} and P. Lakatos",
year = "2015",
month = "3",
day = "1",
doi = "10.1556/OH.2015.30120",
language = "Hungarian",
volume = "156",
pages = "516--520",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "13",

}

TY - JOUR

T1 - A nem szteroid gyulladásgátló készítmények cardiovascularis mellékhatásai a legújabb ajánlások fényében. Nem veszélyesebb a diclofenac

AU - Horváth, Viktor József

AU - Tabák, A.

AU - Szabó, Gergely

AU - Putz, Zsuzsanna

AU - Koós, Csaba Géza

AU - Lakatos, P.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Among their beneficial effects, non-steroidal anti-inflammatory drugs may also exert several side effects which depend on the dosage and the type of these medications. The most frequent gastrointestinal side effects usually develop shortly after the beginning of their administration, but others such as cardiovascular interactions (which are present much less frequently than gastrointestinal side effects) can also occur after the beginning of drug administration without a latency period. For a long-term treatment, non-steroidal anti-inflammatory drugs are most frequently used in the elderly population where patients typically have high cardiovascular risk and take other medicines, e.g. low dose acetylsalicylic acid that can interact with non-steroidal anti-inflammatory drugs; in this aspect diclofenac may cause less side effects. In this review, the authors briefly review cardiovascular side effects of non-steroidal anti-inflammatory drugs, the processes which potentially influence them, therapeutic consequences and their interaction with acetylsalicylic acid.

AB - Among their beneficial effects, non-steroidal anti-inflammatory drugs may also exert several side effects which depend on the dosage and the type of these medications. The most frequent gastrointestinal side effects usually develop shortly after the beginning of their administration, but others such as cardiovascular interactions (which are present much less frequently than gastrointestinal side effects) can also occur after the beginning of drug administration without a latency period. For a long-term treatment, non-steroidal anti-inflammatory drugs are most frequently used in the elderly population where patients typically have high cardiovascular risk and take other medicines, e.g. low dose acetylsalicylic acid that can interact with non-steroidal anti-inflammatory drugs; in this aspect diclofenac may cause less side effects. In this review, the authors briefly review cardiovascular side effects of non-steroidal anti-inflammatory drugs, the processes which potentially influence them, therapeutic consequences and their interaction with acetylsalicylic acid.

KW - acetilszalicilsav

KW - acetylsalicylic acid

KW - cardiovascular side effects

KW - cardiovascularis mellékhatás

KW - diclofenac

KW - diclofenac

KW - nem szteroid gyulladásgátló

KW - non-steroidal anti-inflammatory agents

UR - http://www.scopus.com/inward/record.url?scp=84925680022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925680022&partnerID=8YFLogxK

U2 - 10.1556/OH.2015.30120

DO - 10.1556/OH.2015.30120

M3 - Article

VL - 156

SP - 516

EP - 520

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 13

ER -